Clinical and Demographic Characteristics of 626 Patients with Moderate and Severe Psoriasis

被引:4
|
作者
Rifaioglu, Emine Nur [1 ]
Ozarmagan, Guzin [2 ]
机构
[1] Mustafa Kemal Univ Tayfur Ata Sokmen, Tip Fak, Dermatol Anabilim Dali, TR-31000 Antakya, Hatay, Turkey
[2] Istanbul Univ, Istanbul Tip Fak, Dermatol Anabilim Dali, Istanbul, Turkey
关键词
Psoriasis; Sociodemography; Clinical Features;
D O I
10.4328/JCAM.2413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: In our study, we aim to investigate the demographic, clinic features and the treatments of patients with moderate to severe psoriasis who were followed in outpatient clinic of psoriasis of Department of Dermatology in Istanbul Medical School of Istanbul University. Material and Method: One thousand eight hundred and thirty-one patients, who were followed between 2002-2008 in outpatient clinic of psoriasis. were screened and 626 (34%) of them, who were moderate and severe. were evaluated retrospectively. Results: Three hundred five of the patients who participated in our study were female and 321 were male. Mean age of onset was 28.1. Most frequently clinical type was plaque psoriasis. Most frequently nail involvement was pitting in patients. Nail involvement was statistically common in arthropathic patients. Family history was statistically common in psoriasis patients with early onset Retinoid was the most common used systemic drug. Narrow band UVB was the most common used phototherapy. Discussion: Moderate to severe psoriasis rate was 34%. Female to male ratio was close to one another. Peak age of onset of psoriasis was between 16-25 years old. The most common concomitant systemic disease was diabetes mellitus. The findings were consistent with the literature. Consequently psoriasis is a chronic. recurrent, inflammatory dermatologic disease which affect 2% of the word and which negatively affect the quality of life in patients with comorbidities. Especially in severe forms of psoriasis can cause loss of labor in patients. A good knowledge of demographic and clinical characteristics of psoriasis is important to shedding light on the further clinical studies.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] Impact of baseline characteristics on the efficacy of ixekizumab in patients with moderate to severe psoriasis in a phase 2 study
    Papp, Kim
    Zhu, Baojin
    Leonardi, Craig
    Cameron, Gregory
    Erickson, Janelle
    Heffernan, Michael
    Banerjee, Subhashis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB171 - AB171
  • [42] Study of the Effectiveness of Fumaderm® on Nail Psoriasis in Patients with moderate to severe Psoriasis vulgaris
    Frambach, Y.
    Ludwig, R. J.
    Zillikens, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 108 - 108
  • [43] Nail psoriasis improvement is maintained in patients with moderate to severe psoriasis treated with infliximab
    Rich, P.
    Guzzo, C.
    Li, S.
    Reich, K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB178 - AB178
  • [44] Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis
    Revicki, Dennis A.
    Jin, Ying
    Wilson, Hilary D.
    Chau, Dina
    Viswanathan, Hema N.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 8 - 14
  • [45] PSYCHOMETRIC EVALUATION OF THE PSORIASIS SYMPTOMS SCALE IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Armstrong, A. W.
    Edson-Heredia, E.
    Naegeli, A. N.
    Sun, L.
    Zhu, B.
    Wyrwich, K. W.
    VALUE IN HEALTH, 2018, 21 : S241 - S242
  • [46] Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis
    Hwang, Young Ji
    Youn, Sang Woong
    Kim, Bo Ri
    Yu, Dae Young
    Kim, Youngdoe
    Pires, Antonio
    Cho, Soyun
    Seo, Seong Jun
    Lee, Eun So
    Roh, Joo Young
    Choi, Gwang Seong
    Lee, Min Geol
    JOURNAL OF DERMATOLOGY, 2017, 44 (05): : 560 - 566
  • [47] Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis
    Yamauchi, Paul S.
    Lowe, Nicholas J.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (02) : 202 - 204
  • [48] The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
    Menter, Alan
    Augustin, Matthias
    Signorovitch, James
    Yu, Andrew P.
    Wu, Eric Q.
    Gupta, Shiraz R.
    Bao, Yanjun
    Mulani, Parvez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (05) : 812 - 818
  • [49] Safety of guselkumab in patients with moderate-to-severe psoriasis: Pooled analyses across clinical studies
    Lebwohl, Mark
    Rowland, Katelyn
    Miller, Megan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB106 - AB106
  • [50] Etanercept therapy allows tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis
    Yamauchi, P
    Lowe, N
    Koo, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P185 - P185